{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:39:21Z","timestamp":1792651161651,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K20176"],"award-info":[{"award-number":["25K20176"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Topical ganciclovir (GCV) reduces intraocular pressure (IOP) in patients with cytomegalovirus (CMV) anterior uveitis. Because increased angle pigmentation may contribute to aqueous outflow resistance, we investigated the relationship between angle pigmentation and the IOP-lowering effects of topical GCV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study design<\/jats:title>\n                    <jats:p>Retrospective study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We reviewed the medical records of 31 eyes of 31 patients diagnosed with CMV anterior uveitis using aqueous humor PCR and treated with 2% topical GCV at the University of Tokyo Hospital. The best-corrected visual acuity (BCVA), IOP, topical steroids, and glaucoma medication scores were evaluated at baseline, 1, 4, 12, and 24 weeks after GCV initiation. Pre-treatment angle pigmentation was graded and analyzed in relation to IOP. Survival analysis was performed, with failure defined as an IOP &gt; 21 mmHg, or the need for glaucoma surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Topical GCV improved BCVA with gradual reductions in IOP, steroid use, and glaucoma medication. Angle pigmentation was lower in CMV-affected eyes than in fellow eyes in patients with a shorter disease duration. Higher angle pigmentation was significantly correlated with a longer disease duration (\n                      <jats:italic>\u03c1<\/jats:italic>\n                      = 0.51,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.003). The greater-pigmentation group showed significantly less IOP reduction and lower survival rates than the less-pigmentation group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Angle pigmentation was lower in the affected eyes than in the fellow eyes in patients with a shorter disease duration. In contrast, patients with greater angle pigmentation exhibited longer disease duration and a reduced IOP-lowering response to topical GCV treatment. Therefore, pre-treatment angle pigmentation evaluation may assist in predicting glaucoma outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10384-026-01446-w","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:52:35Z","timestamp":1792648355000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Involvement of ocular angle pigmentation on the effect of 2% topical ganciclovir treatment in patients with cytomegalovirus anterior uveitis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2667-2230","authenticated-orcid":false,"given":"Hotaka","family":"Nemoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Tokuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukako","family":"Taketani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Miyai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4420-2782","authenticated-orcid":false,"given":"Rie","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"1446_CR1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1001\/archopht.1948.00900020525007","volume":"39","author":"A Posner","year":"1948","unstructured":"Posner A, Schlossman A. Syndrome of unilateral recurrent attacks of glaucoma with cyclitic symptoms. Arch Ophthalmol. 1948;39:517\u201335.","journal-title":"Arch Ophthalmol"},{"key":"1446_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/09273948.2023.2228404","volume":"32","author":"Q Sheng","year":"2024","unstructured":"Sheng Q, Sun Y, Zhai R, Fan X, Ying Y, Kong X. 2% Ganciclovir controlled Posner\u2013Schlossman syndrome relapse and reduced the chance of corticosteroid dependence: a large cohort in East China. Ocul Immunol Inflamm. 2024;32:505\u201312.","journal-title":"Ocul Immunol Inflamm"},{"key":"1446_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.survophthal.2016.12.005","volume":"62","author":"R Megaw","year":"2017","unstructured":"Megaw R, Agarwal PK. Posner\u2013Schlossman syndrome. Surv Ophthalmol. 2017;62:277\u201385.","journal-title":"Surv Ophthalmol"},{"key":"1446_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2016-000061","volume":"2","author":"N Keorochana","year":"2017","unstructured":"Keorochana N, Choontanom R. Efficacy and safety of an extemporaneous preparation of 2% ganciclovir eye drops in CMV anterior uveitis. BMJ Open Ophthalmol. 2017;2:e000061. https:\/\/doi.org\/10.1136\/bmjophth-2016-000061.","journal-title":"BMJ Open Ophthalmol"},{"key":"1446_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ophtha.2007.04.053","volume":"115","author":"N Koizumi","year":"2008","unstructured":"Koizumi N, Suzuki T, Uno T, Chihara H, Shiraishi A, Hara Y, et al. Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology. 2008;115:292-7.e3.","journal-title":"Ophthalmology"},{"key":"1446_CR6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.76946","volume":"17","author":"L Chun Heng","year":"2025","unstructured":"Chun Heng L, Muhd Nor NI. Management of glaucoma in cytomegalovirus uveitis: a retrospective case series of surgical and medical approaches. Cureus. 2025;17:e76946. https:\/\/doi.org\/10.7759\/cureus.76946.","journal-title":"Cureus."},{"key":"1446_CR7","first-page":"297","volume":"19","author":"K Shimizu","year":"1965","unstructured":"Shimizu K. A new gonioscopical finding in Posner\u2013Schlossman\u2019s syndrome. Rinsho Ganka. 1965;19:297\u20138 (in Japanese).","journal-title":"Rinsho Ganka"},{"key":"1446_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/00061198-200604000-00011","volume":"15","author":"J Gottanka","year":"2006","unstructured":"Gottanka J, Johnson DH, Grehn F, L\u00fctjen-Drecoll E. Histologic findings in pigment dispersion syndrome and pigmentary glaucoma. J Glaucoma. 2006;15:142\u201351.","journal-title":"J Glaucoma"},{"key":"1446_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/ceo.12737","volume":"44","author":"H Akil","year":"2016","unstructured":"Akil H, Chopra V, Huang A, Loewen N, Noguchi J, Francis BA. Clinical results of ab interno trabeculotomy using the Trabectome in patients with pigmentary glaucoma compared to primary open angle glaucoma. Clin Exp Ophthalmol. 2016;44:563\u20139.","journal-title":"Clin Exp Ophthalmol"},{"key":"1446_CR10","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00417-019-04300-7","volume":"257","author":"C Wang","year":"2019","unstructured":"Wang C, Dang Y, Loewen RT, Waxman S, Shah P, Xia X, et al. Impact of pigment dispersion on trabecular meshwork cells. Graefes Arch Clin Exp Ophthalmol. 2019;257:1217\u201330.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1446_CR11","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0161-6420(01)00551-6","volume":"108","author":"A Jap","year":"2001","unstructured":"Jap A, Sivakumar M, Chee SP. Is Posner\u2013Schlossman syndrome benign? Ophthalmology. 2001;108:913\u20138.","journal-title":"Ophthalmology"},{"key":"1446_CR12","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1001\/archopht.1957.00940010526005","volume":"58","author":"HG Scheie","year":"1957","unstructured":"Scheie HG. Width and pigmentation of the angle of the anterior chamber: a system of grading by gonioscopy. AMA Arch Ophthalmol. 1957;58:510\u20132.","journal-title":"AMA Arch Ophthalmol"},{"key":"1446_CR13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1001\/archopht.1977.04450040074010","volume":"95","author":"C Raitta","year":"1977","unstructured":"Raitta C, Vannas A. Glaucomatocyclitic crisis. Arch Ophthalmol. 1977;95:608\u201312.","journal-title":"Arch Ophthalmol"},{"key":"1446_CR14","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s10384-025-01250-y","volume":"69","author":"Y Yoneda","year":"2025","unstructured":"Yoneda Y, Takenaka Y, Taniguchi N, Yoneda K, Seki K, Oyama T, et al. Efficacy of 2% ganciclovir eye drops in the treatment of cytomegalovirus anterior uveitis. Jpn J Ophthalmol. 2025;69:973\u201381.","journal-title":"Jpn J Ophthalmol"},{"key":"1446_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ajo.2021.03.020","volume":"227","author":"Y Terada","year":"2021","unstructured":"Terada Y, Kaburaki T, Takase H, Goto H, Nakano S, Inoue Y, et al. Distinguishing features of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus. Am J Ophthalmol. 2021;227:191\u2013200.","journal-title":"Am J Ophthalmol"},{"key":"1446_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep43349","volume":"7","author":"JA Choi","year":"2017","unstructured":"Choi JA, Kim J-E, Noh S-J, Kyoung Kim E, Park CK, Paik S-Y. Enhanced cytomegalovirus infection in human trabecular meshwork cells and its implication in glaucoma pathogenesis. Sci Rep. 2017;7:43349. https:\/\/doi.org\/10.1038\/srep43349.","journal-title":"Sci Rep"},{"key":"1446_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018123","volume":"98","author":"K Murata","year":"2019","unstructured":"Murata K, Ishida K, Ozawa K, Sawada A, Mochizuki K, Yamamoto T. The characteristics of Posner\u2013Schlossman syndrome: a comparison in the surgical outcome between cytomegalovirus-positive and cytomegalovirus-negative patients. Medicine (Baltimore). 2019;98:e18123. https:\/\/doi.org\/10.1097\/MD.0000000000018123.","journal-title":"Medicine (Baltimore)"},{"key":"1446_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1550509","volume":"15","author":"F Ehara","year":"2025","unstructured":"Ehara F, Nagase D, Kai M, Adachi K, Miyake H, Shimizu Y, et al. Roles played by IL-8 in altering dynamics of trabecular meshwork cells after human cytomegalovirus infection. Front Cell Infect Microbiol. 2025;15:1550509. https:\/\/doi.org\/10.3389\/fcimb.2025.1550509.","journal-title":"Front Cell Infect Microbiol"},{"key":"1446_CR19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10384-018-0618-1","volume":"62","author":"D Shimizu","year":"2018","unstructured":"Shimizu D, Miyazaki D, Shimizu Y, Hosogai M, Kosugi I, Inoue Y. Infection of endotheliotropic human cytomegalovirus of trabecular meshwork cells. Jpn J Ophthalmol. 2018;62:667\u201376.","journal-title":"Jpn J Ophthalmol"},{"key":"1446_CR20","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1002\/jcp.31097","volume":"238","author":"H Nemoto","year":"2023","unstructured":"Nemoto H, Honjo M, Arai S, Miyazaki T, Aihara M. Apoptosis inhibitor of macrophages\/CD5L enhances phagocytosis in the trabecular meshwork cells and regulates ocular hypertension. J Cell Physiol. 2023;238:2451\u201367.","journal-title":"J Cell Physiol"},{"key":"1446_CR21","first-page":"2499","volume":"30","author":"S Shirato","year":"1989","unstructured":"Shirato S, Murphy CG, Bloom E, Franse-Carman L, Maglio MT, Polansky JR, et al. Kinetics of phagocytosis in trabecular meshwork cells: flow cytometry and morphometry. Invest Ophthalmol Vis Sci. 1989;30:2499\u2013511.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1446_CR22","first-page":"1902","volume":"38","author":"Y Matsumoto","year":"1997","unstructured":"Matsumoto Y, Johnson DH. Dexamethasone decreases phagocytosis by human trabecular meshwork cells in situ. Invest Ophthalmol Vis Sci. 1997;38:1902\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1446_CR23","first-page":"2156","volume":"31","author":"C Buller","year":"1990","unstructured":"Buller C, Johnson DH, Tschumper RC. Human trabecular meshwork phagocytosis: observations in an organ culture system. Invest Ophthalmol Vis Sci. 1990;31:2156\u201363.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1446_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10384-022-00970-9","volume":"67","author":"Y Kiuchi","year":"2023","unstructured":"Kiuchi Y, Inoue T, Shoji N, Nakamura M, Tanito M, Glaucoma Guideline Preparation Committee, Japan Glaucoma Society. The Japan Glaucoma Society guidelines for glaucoma 5th edition. Jpn J Ophthalmol. 2023;67:189\u2013254.","journal-title":"Jpn J Ophthalmol"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01446-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-026-01446-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01446-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:52:36Z","timestamp":1792648356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-026-01446-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":24,"alternative-id":["1446"],"URL":"https:\/\/doi.org\/10.1007\/s10384-026-01446-w","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"7 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H. Nemoto, None; A. Tokuda, None; Y. Taketani, None; D. Shen, None; Y. Miyoshi, None; H. Takase, an inventor on issued patents related to the subject matter of this article; T. Miyai, None; R. Tanaka, None.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}